Browsing Tag
Nilesh Gupta
14 posts
Lupin shocks the market with massive profit gains in Q3 FY2025—here’s what you need to know
Lupin Limited, a leading global pharmaceutical company, has reported strong financial results for the third quarter of fiscal…
Lupin Limited sees explosive profit surge in Q1 FY2025
Lupin Limited has reported a remarkable financial performance for the quarter ending June 30, 2024. The pharmaceutical giant’s…
Zydus and Lupin forge alliance for NAFLD and NASH treatment in India
In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and…
Lupin’s Nagpur Unit-1 gets FDA nod with VAI status
Global pharmaceutical powerhouse, Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United…
Lupin acquires five legacy brands, intensifies Indian pharma dominance
In a move that has set the pharmaceutical industry abuzz, global pharma titan Lupin Limited has revealed the…
Lupin acquires diabetes brands ONDERO and ONDERO MET from Boehringer Ingelheim
In a strategic move to fortify its position in the pharmaceutical domain, global major Lupin Limited proclaimed its…
Lupin Limited continues momentum in Q1 FY2024: Insights into earnings and sales
Pharmaceutical giant Lupin Limited reported its Q1 FY2024 financial performance, indicating a gross profit of INR 31,013 million,…
FDA concludes inspection at Lupin Bioresearch Centre in Pune
Lupin said that the US Food and Drug Administration (FDA) has concluded an inspection of the company’s bioresearch…
Can Lupin’s clean FDA inspection at its Vizag API plant boost confidence in its global supply reliability?
Lupin’s Vizag API plant clears US FDA inspection with no observations, strengthening its US supply reliability and regulatory track record.
Shahin Fesharaki appointed as Lupin Global Chief Scientific Officer
Indian pharmaceutical company Lupin announced that Dr. Shahin Fesharaki has been appointed as Global Chief Scientific Officer who…